-+ 0.00%
-+ 0.00%
-+ 0.00%

Inventiva names Chris Benecchi chief operating officer

PUBT·08/31/2026 20:06:13
Listen to the news
Inventiva names Chris Benecchi chief operating officer
  • Inventiva appointed Chris Benecchi as chief operating officer as it prepares for NATiV3 Phase 3 topline results for lanifibranor in Q4 2026.
  • Benecchi will lead operational readiness ahead of a potential U.S. launch of lanifibranor in 2028, subject to regulatory approval.
  • He was previously CEO of Motric Bio, an Aditum Bio company.
  • Earlier roles included COO, chief business officer, chief commercial officer at Sage Therapeutics, supporting the U.S. launch of ZURZUVAE.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Inventiva SA published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608311605PRIMZONEFULLFEED1001260260) on August 31, 2026, and is solely responsible for the information contained therein.